May 26, the SFC website issued a "Shenzhen Mindray Bio-Medical Electronics Co., Ltd. initial public offering prospectus (draft report in May 2017 to send 16 daily)," which means Mindray official launch of the A-share IPO pace. According to the prospectus, the sponsor institution is BOC International and the joint lead underwriters are BOC International and Huatai United Securities.
According to the prospectus, Mindray has 57 wholly-owned or holding subsidiaries (including direct and indirect subsidiaries), including 18 in China and 39 overseas. In 2016, the company's operating income was 9.031 billion yuan, the largest in China. The medical device sales company, followed by Xinhua Medical and Lepu Medical. As an international company, its overseas sales accounted for half of the total. The proportion in 2014-2016 was 54.91%, 53.72% and 50.00% respectively.
Equity composition
As of the signing date of the prospectus, the company's total share capital is about 1.094 billion yuan (10,940.126 million), the issue is 121.6 million shares, and the proportion of public shares issued after the issuance is not less than 10%. The stock has a face value of 1 yuan.
The total profit
Dental Sterilizer,Podiatry Sterilizer,Dental Sterilization,Dental Sterilization Equipment
ZHEJIANG FOMOS MEDICAL TECHNOLOGY CO.,LTD. , https://www.ifomos.com